Teon Therapeutics Inc.

Teon is a clinical company targeting metabolic signaling pathways and pioneering the development of GPCR therapies

Add To Watchlist
General Information
Company Name
Teon Therapeutics Inc.
Founded Year
2017
Location (Offices)
Redwood City, United States +1
Founders / Decision Makers
Serge Messerlian - Co-Founder & Chief Executive Officer Lina Yao - Founder & CSO
Number of Employees
6
Industries
Biopharma, Biotechnology, Health Care +1
Funding Stage
Series A
Social Media

Teon Therapeutics Inc. - Company Profile

Teon Therapeutics Inc. is a clinical company targeting metabolic signaling pathways and pioneering the development of GPCR therapies. Founded in 2017, the company operates in the fields of Biopharma, Biotechnology, Health Care, and Pharmaceuticals. Hailing from the United States, Teon received a significant $30.00M Series A investment on 23 February 2021, with participation from Northern Light Venture Capital, Oriza Ventures, Kaitai Capital, Oceanpine Capital, Oriental Fortune Capital, and Lifespan Investments. With its focus on immunotherapies for difficult-to-treat cancers, Teon holds promise for both patients and investors. Its innovative approach and strong investor backing position it well for further growth and impact in the biopharmaceutical industry.

Taxonomy: clinical company, metabolic signaling pathways, GPCR therapies, clinical-stage, biopharmaceutical company, cancer patients, small molecules, immunosuppressive signaling pathways, tumor microenvironment, A2BR-specific antagonist, Phase 1b trials, cancer research, immunotherapy, oncology, drug development

Funding Rounds & Investors of Teon Therapeutics Inc. (2)

View All
Funding Stage Amount No. Investors Investors Date
Series A $30.00M 6
Northern Light Venture Capital, investor in Teon Therapeutics Inc.'s Series A round Oriza Ventures, investor in Teon Therapeutics Inc.'s Series A round Kaitai Capital, investor in Teon Therapeutics Inc.'s Series A round Oceanpine Capital, investor in Teon Therapeutics Inc.'s Series A round Oriental Fortune Capital, investor in Teon Therapeutics Inc.'s Series A round
Lifespan Investments 		23 Feb 2021
Seed Round $7.00M 1
Northern Light Venture Capital, investor in Teon Therapeutics Inc.'s Seed Round round
01 Jan 2019

Latest News of Teon Therapeutics Inc.

View All

No recent news or press coverage available for Teon Therapeutics Inc..

Similar Companies to Teon Therapeutics Inc.

View All
Lixte Biotechnology Holdings, Inc. - Similar company to Teon Therapeutics Inc.
Lixte Biotechnology Holdings, Inc. Lixte Biotechnology (Nasdaq: LIXT)
Semafore Pharmaceuticals - Similar company to Teon Therapeutics Inc.
Semafore Pharmaceuticals Pioneering the future of cancer treatment with innovative PI3K inhibitors.
Georgiamune Inc. - Similar company to Teon Therapeutics Inc.
Georgiamune Inc. Georgiamune is reprogramming immune signaling pathways to redirect the immune system to fight diseases.
Complexa - Similar company to Teon Therapeutics Inc.
Complexa Advancing therapeutic innovation in human cell signaling for inflammation, fibrosis, and CNS disease treatment solutions.
InnoSIGN - Similar company to Teon Therapeutics Inc.
InnoSIGN Comprehensive Pathway Analysis
Circle Decoration Circle Decoration

Want to dive deeper into Teon Therapeutics Inc.? Join now to access exclusive insights and find similar companies like this — powered by AI analytics.

Register Now